Potential lipid-based strategies of amphotericin B designed for oral administration in clinical application
Amphotericin B (AmB) is regarded as a first-line therapy against life-threatening invasive fungal infections. Due to its poor oral bioavailability, AmB is restricted to intravenous administration in clinical practice. As science continues to move forward, two lipid-based formulations are successfull...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis Group
2023-12-01
|
| coleção: | Drug Delivery |
| Assuntos: | |
| Acesso em linha: | https://www.tandfonline.com/doi/10.1080/10717544.2022.2161671 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|